To predict a persons vulnerability to type 2 diabetes and their chance of benefiting from particular dietary patterns, like the Mediterranean diet or low-carb diets, genetic risk scores, or GRS, have been developed (166)
To get a chemists perspective, Ursula Diaz, co-founder of Honor MD, reviewed the ingredient lists for the GLP-1- products
Rivett, M., & Gupta, R
Addition of a dipeptidyl peptidase-4 inhibitor, sitagliptin, to ongoing therapy with the glucagon-like peptide-1 receptor agonist liraglutide: A randomized controlled trial in patients with type 2 diabetes
EFORT Open Rev
Leveraging a vertically-integrated, proprietary digital care platform, a 50-state affiliated medical group, and a US-based patient care center, LifeMD is elevating healthcare by increasing access to top-notch and affordable care